Inventor · disambiguated record
Pavel Safar
Also filed as: SAFAR PAVEL
13 granted patents·1 pending application·72 citations·filing 1997–2012
88Inventor score
Files withAVENTIS PHARMA INC5SANOFI AVENTIS DEUTSCHLAND4AVENTIS PHARMA GMBH2SANOFI SA1SELECTIDE CORP1
Top patents by PatentIndex Score
14 records- 0191US7994168B2Hexahydro-pyrazino[1,2-A]pyrimidine-4,7-dione derivatives substituted with amino acidsSANOFI AVENTIS DEUTSCHLAND·Filed 2007·Granted Aug 9, 2011·28 cites·2 claims
- 0279US6500803B1Factor VIIa inhibitorsAVENTIS PHARMA GMBH·Filed 2000·Granted Dec 31, 2002·14 cites·12 claims
- 0363US6777577B2Substituted amides, sulfonamides and ureas useful for inhibiting kinase activityAVENTIS PHARMA INC·Filed 2002·Granted Aug 17, 2004·1 cites·12 claims
- 0461US7393849B2Substituted sulfonamides and ureas useful for inhibiting kinase activityAVENTIS PHARMA INC·Filed 2007·Granted Jul 1, 2008·0 cites·15 claims
- 0561US7323457B2Substituted sulfonamides and ureas useful for inhibiting kinase activityAVENTIS PHARMA INC·Filed 2007·Granted Jan 29, 2008·0 cites·17 claims
- 0658US7750005B2Substituted hexahydropyrazino [1,2-A] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicamentsSANOFI AVENTIS DEUTSCHLAND·Filed 2008·Granted Jul 6, 2010·0 cites·2 claims
- 0757US7223763B2Substituted sulfonamides and ureas useful for inhibiting kinase activityAVENTIS PHARMA INC·Filed 2004·Granted May 29, 2007·0 cites·16 claims
- 0856US5849510AFactor Xa inhibitorsSELECTIDE CORP·Filed 1997·Granted Dec 15, 1998·10 cites·43 claims
- 0955US6287794B1Factor Vlla inhibitorsAVENTIS PHARMA GMBH·Filed 1999·Granted Sep 11, 2001·14 cites·25 claims
- 1051US7390814B2Substituted hexahydropyrazino [1,2-a] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicamentsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Jun 24, 2008·0 cites·6 claims
- 1148US6759384B1Factor Xa inhibitorsAVENTIS PHARMA INC·Filed 1998·Granted Jul 6, 2004·5 cites·10 claims
- 1248US2003045480A1Method of treating hyperresorptive bone disordersFiled 2002·Application pending·0 cites
- 1342US7652007B2Nitrogen-substituted hexahydropyrazino[1,2-A]pyrimidine-4,7-dione derivatives, processes for their preparation and their use as medicamentsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Jan 26, 2010·0 cites·5 claims
- 1439US8791133B2Pyridylvinylpyrazoloquinolines as PAR1 inhibitorsSANOFI SA·Filed 2012·Granted Jul 29, 2014·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Pavel Safar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →